InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: DewDiligence post# 7720

Friday, 05/31/2013 4:15:10 PM

Friday, May 31, 2013 4:15:10 PM

Post# of 426707
I am not sure if they correlate! If anything Vascepa will replace statin therapy. Just look at the some of the latest study's. The approach taken to lower LDL, maybe wrong all together. You are really comparing apples and oranges here.

High dosage (pure EPA) Omega-3's have more value reducing CV events. Has beneficial effects on coronary plaque stabilization, independent of LDL-C levels.

In time Vascepa will be the standard of care rather than statins.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News